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NecrosisApoptosis and necrosis are the twomajor modes of cell death, the molecular mechanisms of which have been
extensively studied. Although initially thought to constitute mutually exclusive cellular states, recent ﬁndings
reveal cellular contexts that require a balanced interplay between these two modes of cellular demise. Sev-
eral death initiator and effector molecules, signaling pathways and subcellular sites have been identiﬁed as
key mediators in both processes, either by constituting common modules or alternatively by functioning as
a switch allowing cells to decide which route to take, depending on the speciﬁc situation. Importantly, au-
tophagy, which is a predominantly cytoprotective process, has been linked to both types of cell death, serving
either a pro-survival or pro-death function. Here we review the recent literature that highlights the intricate
interplay between apoptosis, necrosis and autophagy, focusing on the relevance and impact of this crosstalk
in normal development and in pathology. This article is part of a Special Section entitled: Cell Death Pathways.
Guest Editors: Frank Madeo and Slaven Stekovic.
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Distinct modes of cell death were for a long time studied in isola-
tion, as the prevailing model suggested that they represented mutual-
ly exclusive cellular states. However, the past decade has witnessed a
steady accumulation of ﬁndings suggesting that apoptosis, necrosis
and autophagy are often regulated by similar pathways, engageK, Adenosine Monophosphate
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l rights reserved.common sub-cellular sites and organelles, and even share initiator
and effector molecules. Depending on the cellular context and death
trigger, the two main modes of cell death often co-operate in a bal-
anced interplay that involves autophagy, or they are employed by
cells in a complementary fashion to facilitate cellular destruction.
Apoptosis has been intensively studied in the past two decades
and is widely appreciated as a major mechanism of regulated death,
employed not only upon cell damage or stress, but also during normal
development and morphogenesis. For example, the peripheral ner-
vous system of vertebrates is shaped by the apoptotic death of almost
half of the new born peripheral neurons during development in order
to regulate their number such that it matches to the need of their tar-
get tissues in the periphery [1]. Apoptosis may be triggered either by
extrinsic stimuli through cell surface death receptors, such as TNFα
(tumor necrosis factor-α), Fas (CD95/APO1) and TRAIL (TNF related
apoptosis inducing ligand) receptors or by intrinsic stimuli via the
mitochondrial signaling pathway [2,3]. In either case, activation of
cysteine aspartyl proteases, called caspases, results in mitochondrial
membrane permeabilization, chromatin condensation and DNA frag-
mentation, thereby leading to the destruction of the cell [4]. These
events bestow the apoptotic cell a distinct and characteristic mor-
phology (Fig. 1c) that includes the rounding up of the cell so that it
appears pyknotic, the condensation of chromatin, the fragmentation
of the nucleus and the shedding of apoptotic bodies, vacuoles
containing cytoplasm and intact organelles.
Apoptosis has been classically contrasted to pathological necrosis,
which for a long time was thought to represent a diametrically “oppo-
site” mode of unordered and passive cellular explosion in response to
acute and overwhelming trauma. Morphologically, necrotic cells are
characterized by the swelling of organelles, such as the endoplasmic
Fig. 1. Types of cell death and their morphological hallmarks. Diagrammatic classiﬁcation of different types of cell death. PCD: programmed cell death. Morphological features of a) a
healthy cell, b) a necrotic cell, c) an apoptotic cell and d) an autophagic cell. (Electron micrograph pictures adapted from ref. [150]. Scale bar: 1 mm.)
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the lysis of the cell [5,6], while, unlike in apoptosis, the nucleus becomes
distended and remains largely intact (Fig. 1b). Necrotic death is typically
followed by inﬂammatory reactions [7]. Necrotic cells selectively release
factors like HMGB1 and HDGF to evoke an inﬂammatory response [8]
and are sensed by NLRP3, a core protein of the inﬂammasome, resulting
in inﬂammasome activation and the subsequent release of the pro-
inﬂammatory cytokine IL1β. NLRP3 inﬂammasome activation is trig-
gered mainly through ATP produced by mitochondria released from
damaged cells [9]. Mechanistically, necrosis is typically not associated
with activation of caspases, and it is thought that it mediates cell demise
in response to damage, or in pathology [10,11], but not during normal
development. Despite this, it turns out that a programmed form of ne-
crotic death (termed necroptosis) is very common in vivo, not only in
physical traumas, but mainly in diverse forms of neurodegeneration,
and death inﬂicted by ischemia or infection. In addition, progress in the
ﬁeld has revealed that unlike unordered necrosis, this more physiologi-
cal and programmed type of necroptotic death shares several key pro-
cesses with apoptosis, as discussed later.
A cellular process that has been involved in both main types of cell
deathmentioned above ismacroautophagy (hereafter referred to as au-
tophagy), a self-cannibalization mechanism that involves the engulf-
ment of cytoplasmic material and intracellular organelles within
double-membrane vesicles, called autophagosomes. Completion of the
autophagosome is followed by fusion with a lysosome to form an
autolysosome, where the captured material is degraded by speciﬁc
acidic hydrolases [12]. Although it is primarily considered to have a
cytoprotective function, autophagy can also promote cell death duringnormal development (reviewed in [13]), as well as, in disease
(reviewed in [14]). A low level of constitutive autophagy has an impor-
tant housekeeping role in the normal turnover of long-lived proteins
and whole organelles, thereby being crucial for maintaining healthy
cells. The homeostatic role of autophagy is particularly critical in
post-mitotic differentiated cells, such as neurons and cardiomyocytes.
Starvation and other environmental and hormonal cues such as nutri-
ent deprivation, growth factor depletion and hypoxia are known to ac-
tivate autophagy [15,16]. As a consequence, degradation of cytoplasmic
components is enhanced in response to stress conditions, thereby
promoting survival. However, excessive autophagy or activation of
autophagy in the context of speciﬁc diseases may be harmful. Indeed,
accumulating evidence, discussed below, reveals that autophagy is
linked to cell death under certain circumstances. Here, we overview
the recent literature on the interplay between cell death mechanisms
and autophagy. Our aim is to highlight the cellular states, sub-cellular
sites and signaling mechanisms that participate in, and are crucial for
this interplay, the signiﬁcance of which during normal development
and disease is currently being explored.
2. Crosstalk between apoptosis and necrosis
2.1. Programmed necrosis: necroptosis
In the late 1980s it became clear that necrosis can also function as
an alternative programmed mode of cell death, triggered by the same
death signals that induce apoptosis. More speciﬁcally, it was shown
that while in F17 cells TNFα treatment induced a classical form of
3450 V. Nikoletopoulou et al. / Biochimica et Biophysica Acta 1833 (2013) 3448–3459apoptosis, in a different cell type, the L-M cells, it induced a necrotic
form of cell death [17]. The term “necroptosis” was later introduced
to describe the cases where necrosis represented a regulated and
programmed form of death, instead of an accidental death, and
which is yet distinct from apoptosis. In addition to TNFR1, a number
of death receptors, including FAS [18], TNFR2, TRAILR1 and TRAILR2
[19–21] that typically induce apoptosis, have also been clearly
shown to induce necroptosis in different cell types. This is particularly
the case when apoptosis has been blocked (for instance by the use of
caspase inhibitors), as shown for T cells [22], or under low levels of
ATP [7,23]. In addition to death receptors, necroptosis can also be
initiated by members of the pathogen recognition receptor (PRR)
family, that are expressed by cells of the innate immune system to
sense pathogen-associated molecular patterns (PAMPs; reviewed in
ref. [24]). However, the downstream death signaling events remain
poorly characterized.
By contrast, the signaling cascade downstream of TNFα leading to
necroptosis has been studied in detail [25–29] (Fig. 2). Brieﬂy, in the ab-
sence of TNFα, TNFR1 subunits spontaneously trimerize at the plasma
membrane. Upon ligand binding, these receptor trimers undergo a con-
formational change that allows their cytosolic tails to recruit multipleFig. 2. TNFα induces both apoptosis and necroptosis via distinct signaling pathways. Sche
emerges from recent ﬁndings. Inhibition of caspases by zVAD is required in many experimen
PARP1 and AKT were recently shown to be directly activated by RIP1, contributing to the ne
NEMO functions as an essential component of the necroptosis-inducing complex II. See texproteins, including TNFR-associated death domain (TRADD), RIP1, cel-
lular inhibitor of apoptosis 1 (cIAP1), cIAP2, TNFR-associated factor 2
(TRAF2) and TRAF5. As a result, a large structure is generated proximal-
ly to the plasmamembrane, termed complex I [30], which activates the
pro survival NF-κB signaling pathway.
Binding of TNFα to TNFR1 leads to its internalization and the forma-
tion of a cytosolic death-inducing signaling complex (DISC), also known
as complex II [24,31]. RIP1 polyubiquitylation not only affects NF-κB ac-
tivation but also inﬂuences the transition from complex I to complex II.
Deubiquitylated RIP1 (alongwith its cognate kinase RIP3) is recruited to
a complex that includes TRADD, FAS-associated protein with a death
domain (FADD) and caspase-8. In complex II, RIP1 and RIP3 are
inactivated by proteolytic cleavage by caspase-8, thereby initiating the
pro-apoptotic caspase activation cascade [28,32]. Inhibition of cIAPs
prevents RIP1 ubiquitylation and favors the formation of complex II,
thus sensitizing cells to RIP1-dependent activation of caspase-8 and
apoptosis [33]. By contrast, when caspase-8 is deleted, depleted or
inhibited, complex II cannot initiate the apoptotic program [34,35]
and ligation of TNFR1 results in necroptosis (Fig. 2) [20] (reviewed in
detail elsewhere [24]). Recent work performed in mouse embryonic ﬁ-
broblasts indicates that in addition to RIP1 and RIP3, the adaptor proteinmatic representation of TNFα signaling to apoptotic and necroptotic cell death, as it
tal models for the facilitation of the necroptotic program downstream TNFR activation.
croptotic phenotype by reducing ATP levels and activating JNK respectively. Moreover,
t for details.
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of TNFα-induced RIP1-RIP3 necroptotic complex is independent of
cytosolic Ca2+ [36]. Furthermore, the same study demonstrates that
FADD–RIP1–RIP3-mediated mitochondrial malfunction is dependent
on TNFα signaling molecule NEMO, a key mediator of cytokine-
induced necroptosis. It is thus proposed that a FADD–RIP1–RIP3–
NEMO complex induces BAX/BAK-dependent disintegration of mito-
chondrial bioenergetics to promote TNFα-driven necroptosis.
Recent work has also identiﬁed new components of the necrosome
(reviewed in [37]). The mixed lineage kinase domain-like protein
(MLKL) has also been identiﬁed as an interacting partner of RIP3 and
thus a component of the necrosome [38]. Subsequent ﬁndings further
supported the hypothesis that MLKL is indeed required for TNFa in-
duced necroptosis [39], as MLKL mutants that cannot be phosphorylat-
ed at key residues prevented the activation of the necrosome despite
still being able to incorporate into the necrosomal complex. Inte-
restingly, PGAM5, a mitochondrial phosphoglyceratemutase, was
also recently reported to associate with the necrosome, providing
a potential point of convergence for increased mitochondrial ﬁssion
and necroptosis ([40,41]; reviewed in [37]).
At the level of signaling, several recent studies have shed light on
the close interplay between apoptosis and necroptosis. Analysis of
FADD/RIP3 and FLIP/RIP3 double knockouts, revealed an intricate
cross regulation of apoptosis and necrosis. Brieﬂy, FLIP prevents the
assembly of FADD-dependent, caspase-8 homodimers that mediate
apoptosis, while at the same time the resulting caspase-8-FLIP
heterodimers prevent the activation of RIP3 that mediates necrosis.
In the absence of this heterocomplex RIP3 promotes necrosis, while
in the presence of FADD but absence of FLIP, caspase-8 drives apopto-
sis. Deregulation of either pathway during development results in
embryonic lethality [42].
In another study, using L929 cells, it was demonstrated that dur-
ing necroptosis, AKT is activated in a RIP1 dependent fashion through
its phosphorylation on Thr308. AKT activity, mediated in part through
mTORC1, links RIP1 to JNK activation and autocrine production of
TNFα. In other cell types, such as mouse lung ﬁbroblasts and macro-
phages, AKT activation resulted in TNFα production without however
contributing to cell death [43]. Activation of AKT appears to act as a
switch, since in addition to facilitating the necroptotic response, it
also acts to inhibit apoptosis. AKT ability to prevent apoptosis in
some cells is established through phosphorylation and inhibition of
pro-apoptotic mediators such as Bad and caspase-9 [44]. In other sit-
uations, AKT activates the transcription factor CREB, and the IκB ki-
nase (IKK), a positive regulator of NF-κB, to regulate the expression
of genes with anti-apoptotic activity [45,46].
Although there have been many reports indicating that necroptosis
takes place upon death receptor activation in conditions where apopto-
sis is blocked, an important question is whether it also occurs in physi-
ological conditions. Some progress has been made towards this end,
especially in the immune system. Using cells infected with vaccinia
virus, a natural condition was illustrated for the ﬁrst time in 2003, in
which apoptosis is inhibited and necrosis takes over (like many other
viruses, vaccinia encodes an anti-apoptotic protein). Upon addition of
the pro-inﬂammatory TNFα, also likely to be present during an
anti-viral immune response, necrotic rather than apoptotic death is in-
duced in infected cells. Although it has long been known that viruses
encode anti-apoptotic proteins to prevent their host cells from killing
themselves by apoptosis, this work also demonstrates that viruses har-
bor proteins that suppress programmed necrosis [19]. It remains to be
ﬁrmly demonstrated whether these anti-necrotic proteins are neces-
sary for viral pathogenicity. However, in support of this notion, it has
been observed that mice lacking the TNFR2 protein (and therefore deﬁ-
cient in the necrotic response to vaccinia infection) exhibit both re-
duced inﬂammation in response to infection and decreased clearance
of the virus. Thus, programmed necrosis might not simply be a backup
when apoptosis fails, but might serve an important function in ﬁghtingmicrobial infection [19]. Moreover, it was recently demonstrated that
RIP kinase-dependent necrosis drives TNF-induced systemic inﬂamma-
tory response syndrome [47].
In addition, it was recently shown that acidic extracellular pH (pHe)
switches TRAIL-induced apoptosis to regulatednecrosis (or necroptosis)
in human HT29 colon and HepG2 liver cancer cells. Knockdown of RIP1
or PARP1 or pretreatment with pharmacological inhibitors inhibited
both TRAIL-induced necroptosis and PARP1-dependent intracellular
ATP depletion demonstrating that RIP1 and RIP3 were involved up-
stream of PARP1 activation and ATP depletion. In line with this, in the
mousemodel of ConA-induced hepatitis, wheredeath ofmousehepato-
cytes is dependent on TRAIL, PARP1 activity was positively correlated
with liver injury and hepatitis [21]. These results underline the clinical
relevance of the necroptotic pathway and the need for identifying com-
ponents of this pathway that may be promising therapeutic targets for
treatment of immunological disorders.
2.2. The role of ATP
Intracellular ATP levels have a determining role in the interplay
between apoptosis and necrosis: high ATP levels typically enable a
cell to undergo apoptosis, whereas low ATP levels favor necrosis.
Thus, depletion of intracellular ATP levels switches the energy-
requiring apoptotic cell death to necrosis [7,48]. It is worth noting,
however, that necrosis still requires some levels of ATP, as complete
ATP depletion triggers yet a different cellular demise that is morpho-
logically and mechanistically distinct from both apoptosis and necro-
sis [23].
Given the central role of energy in the decision of a cell between
the two modes of cell death, mitochondria are key organelles in this
context. TNFα, the best characterized necrosis-inducing ligand, has
a direct involvement on mitochondrial ATP production, as well as
the generation of reactive oxygen species (ROS; [23]). TNFα also in-
duces the activation of PARP1 (presumably via mitochondrial ROS,
causing DNA-damage) leading to ATP depletion and subsequent ne-
crosis [7]. PARP1 is a nuclear enzyme involved in DNA repair, DNA
stability and transcriptional regulation, and becomes activated by
DNA damage [5,7]. Its inhibition in cells exposed to genotoxic factors
leads decreased rates of DNA repair and increased ROS [49,50]. PARP1
over-activation consumes large amounts of NAD+, resulting in a
massive ATP depletion [51,52]. Therefore, PARP1 functions as a mo-
lecular switch between apoptosis and necroptosis by regulating ATP
levels in the cell.
2.3. p53, apoptosis and necrosis
p53 has a pivotal role in sensing cellular stress as it responds to a
wide range of signals includingDNAdamage, oxidative stress and ische-
mia. In turn, it controls programs of apoptosis typically by inducing the
transcription of components of the death receptor and mitochondrial
pathways such as CD95, PUMA, NOXA, BAX, and others, which act coop-
eratively to promote cell death [53,54]. Moreover, p53 can directly pro-
mote mitochondrial outer membrane permeabilization (MOMP) to
trigger apoptosis by modulating the MOMP governing BCL-2 family
[55,56]. A p53-orchestrated mitochondrial apoptotic program has
been described by several groups. Upon stress, a cytoplasmic pool of
p53 rapidly translocates to themitochondrial surface, where it physical-
ly interacts with both anti- and pro-apoptotic BCL-2 family members to
inhibit or activate their respective functions, leading to MOMP and ap-
optosis [57].
A clear case where interplay of apoptosis and necrosis takes place
depending on the magnitude of the death insult is during ischemic
brain infarction, where an apoptotic penumbra surrounds a necrotic
center [8]. The long-standing paradigm had been that p53 controls ap-
optosis but plays no role in necrosis. Only recently the very ﬁrst link be-
tween p53 and necrosis was reported. Upon etoposide-mediated DNA
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largely controlled by p53-mediated transcription of cathepsin Q in co-
operation with DNA damage-induced ROS [58]. Notably, this transcrip-
tional p53–cathepsin Q pathway is dispensable in the necrotic death of
the correspondingwildtypeMEFs. In contrast, H2O2-induced necrosis in
double knockout MEFs was found to be completely transcription inde-
pendent [58]. Necrosis in ischemic tissues depends on cyclophilin D
(CypD), the key regulator of the mitochondrial permeability transition
pore (PTP) at the inner membrane, whose opening leads to cell death
[59]. As shown in four independent strains, CypD null mice are resistant
to ischemia-induced necrosis in myocardial infarction and stroke, and
CypD-deﬁcient mitochondria and cells are resistant to Ca2+ and H2O2-
induced cell death.
In line with these observations, a recent report provides compel-
ling evidence that p53 has a novel role as a modulator of necrosis.
Using H2O2 treatment of cultured cells to model necrosis in ischemic
tissues, p53 was found to be required for necrotic cell death activation
[56]. It does so by accumulating in the mitochondrial matrix, where it
triggers PTP opening, mPT and necrosis by physical interaction with
the critical PTP regulator CypD. This p53 action is transcription-
independent and inhibited by the speciﬁc CypD inhibitor CsA, and
by genetic CypD deletion or knockdown [56].
2.4. BCL-2 proteins in apoptosis and necroptosis
BCL-2 family members regulate the mitochondrial pathway of
apoptosis by complex interactions that determine the integrity of the
outer mitochondrial membrane [60,61]. As already mentioned, this
pathway is initiated byMOMP,which allows soluble proteins (e.g., cyto-
chrome c) in themitochondrial intermembrane space to diffuse into the
cytosol. Cytochrome c causes Apoptotic Protease Activating Factor 1
(APAF1) to oligomerize into a caspase activation complex, termed the
apoptosome. This binds and promotes the activation of initiator
caspase-9, which then activates executioner caspases-3 and -7 that
cleave several substrates to elicit the apoptotic phenotype [62].
The BCL-2 family of proteins is subdivided into three groups
depending on their function [60]. The ﬁrst group consists of BCL-XL,
BCL-2, BCL-W and MCL-1. They contain three or four BCL-2 homology
(BH) domains that are known to be necessary for their anti-apoptotic
function. Through their interactions with other BCL-2 members, they
negatively regulate themitochondrial release of pro-apoptotic proteins.
The second group includes pro-apoptotic proteins, such as BAX and
BAK, which are able to form pores or associate with pore-forming pro-
teins in the outer mitochondrial membrane. This process induces mito-
chondrial permeabilization and the release of cell death-promoting
proteins. The third group consists of proteins that only have a short
BH3 domain. These BH3-only proteins interact with both anti- and
pro-apoptotic BCL-2 members to induce programmed cell death [60].
While BCL-2 family members have well established roles in apo-
ptosis, their involvement in necroptosis is only recently beginning
to unravel. An early indication for the involvement of BCL-2 in necrot-
ic death came from studies on models of insulin-dependent diabetes
mellitus, a chronic autoimmune disease resulting from progressive
destruction of the insulin-producing β-cells in the pancreas [63]. It
has been clearly demonstrated that β-cells die by apoptosis in re-
sponse to a variety of stimuli [64,65] and that their death can be
prevented by overexpression of BCL-2 [66–68]. However, necrosis is
also thought to occur at the early phases of the disease when activat-
ed macrophages are drawn into the tissue. Using the rat insulin-
producing β-cell line RINm5F, it was shown that both apoptosis and
necrosis of these cells, induced by treatment with various cytokines,
could be prevented by overexpression of BCL-2 [69]. Moreover,
overexpression of BCL-2 was also found sufﬁcient to prevent the ne-
crotic death of neuronal [70] and non-neuronal cells [71].
Necroptosis is known to be induced by high doses of the alkylating
DNA-damage agent. N-methyl-N0-nitro-N0-nitrosoguanidine (MNNG)[72]. This necroptotic process, which is also regulated by the kinase
RIP1[73] is executed by the activation of PARP1, Ca2+-dependent
calpain Cys-proteases, and the pro-apoptotic BAX [74]. In MNNG-
induced necroptosis, the key role of the two ﬁrst subgroups of the
BCL-2 family has been recently established: BCL-2 and BAX manage
the mitochondrial release of tAIF [74]. Recent work revealed that BID
regulates BAX activation and necroptosis. Cleaved into tBID via a calpain
cleavage at Gly70, this BH3-only protein is indeed the link between
calpains and BAX in MNNG-mediated necroptosis [75]. Along similar
lines, the pro-cell-death BCL-2-family proteins BAX and BAK were
shown to be required for mitochondrial dysfunction in response to
necroptotic agonists, in mouse embryonic ﬁbroblasts, while over-
expression of BCL-XL is protective [36].
2.5. Necroptosis and apoptosis-like death: the role of AIF and PARP1
The term “apoptosis-like” programmed cell death (Fig. 1) has been
introduced to describe cases where death with apoptotic features,
such as nuclear chromatin condensation morphology takes place in
a caspase-independent manner [76]. This type of programmed cell
death is controlled by mitochondria and its major effector is the mito-
chondrial protein AIF [77,78]. AIF is a ﬂavoprotein, located in the
inter-membrane space of mitochondria and embedded in the inner
mitochondrial membrane. AIF is required for the maintenance of the
mitochondrial respiratory complex I, and displays NADH oxidoreduc-
tase and peroxide scavenging activities [79]. In addition to this func-
tion, AIF has also been implicated as an inducer of apoptotic-like
cell death in several experimental models [76]. This activity is associ-
ated with the cleavage of AIF into a soluble form (tAIF) by calpains or
cathepsins, its release from mitochondria and translocation into the
nucleus. This release is typically either upon increased levels of intra-
cellular Ca2+ or extensive DNA damage. In the former case, increased
intracellular Ca2+ levels trigger depolarization of mitochondrial
membrane, loss of membrane potential, generation of reactive oxy-
gen species (ROS) and AIF release.
Although initially considered speciﬁc to apoptotic-like cell death,
AIF has also been implicated in necroptotic death induced by DNA
damage, triggered by MMNG. In this case, AIF release from the mito-
chondrial inter-membrane space follows the over-activation of
PARP1. Chemical inhibition or genetic ablation of PARP1, as well as
of AIF prevent DNA-damage-induced death, [73,74,80] further dem-
onstrating the absolute requirement of PARP1 and AIF in necroptosis.
Therefore, these effectors appear both in programmed necrosis and
apoptosis-like PCD.
3. Crosstalk between autophagy and apoptosis
Both autophagy and apoptosis are well-controlled biological pro-
cesses that play essential roles in development, tissue homeostasis
and disease. Interactions among components of the two pathways in-
dicate a complex cross-talk, which is often induced by similar stimuli.
For example, studies show that both apoptosis and autophagy are ac-
tivated in response to metabolic stress. Growth factor deprivation,
limitation of nutrients and energy metabolism, activate the LKB1–
AMPK pathway, thereby increasing stability of cyclin-dependent ki-
nase inhibitor p27kip1 and thus promoting cell survival through in-
duction of autophagy. Conversely, knockdown of p27kip1 under
these conditions activates apoptosis [81].
Moreover, autophagy is induced as an adaptive response against
endoplasmic reticulum (ER) stress. Interestingly, perturbation of ei-
ther ER calcium homeostasis or ER function increases autophagy
and apoptotic cell death. The impact of autophagy on cell survival in
the ER stress depends on the tissue type. In colon and prostate cancer
cells, ER-induced autophagy has an important role in disposing of
unwanted polyubiquitinated protein aggregates, thus protecting
against cell death. However, in normal human colon cells and in
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alleviate ER stress but rather contributes to ER-induced apoptosis
[82]. Accumulating evidence reveals that autophagy and apoptosis
can cooperate, antagonize or assist each other, thus inﬂuencing differ-
entially the fate of the cell. Recent studies have delineated several
pathways that mediate the complex interplay between autophagy
and apoptosis providing mechanistic insight into the network that
regulates both processes.
3.1. The TOR kinase pathway in autophagy and apoptosis
The mammalian target of rapamycin (mTOR) kinase integrates
signals from nutrients, growth factors, energy and stress to regulate
growth during early development, and ageing during adulthood.
Low insulin–IGF1 signaling, nutrient or energy limitation and stress
converge to downregulate the activity of TOR [83]. TOR inhibition re-
sults in reduction of mRNA translation rates, as well as, in induction of
autophagy. Under starvation conditions, TOR is rapidly inhibited and
this activates autophagy [84]. Intriguingly, a recent study suggests
that mTOR signaling is inhibited during autophagy initiation, but
reactivated upon prolonged starvation. As a consequence, reactivated
mTOR attenuates autophagy and generates proto-lysosomal tubules
and vesicles that extrude from autolysosomes. These mature into
functional lysosomes, thereby restoring lysosome homeostasis [85].
This negative feedback mechanism ensures the reversion of autophagy
upon nutrient replenishment and as such prevents excess cytoplasmic
vacuolization, which could lead to autophagic cell death [86–88].
mTOR has been reported to have pleiotropic effects on apoptosis
that are most likely dependent on the cellular context as well as di-
verse downstream targets, such as p53, BAD and BCL-2 proteins,
among others [89]. Recently, two new mTOR interactors have been
identiﬁed, the proline-rich AKT substrate (PRAS40) and the protein
Q6MZQ0/FLJ14213/CAE45978, which appear to be implicated in the
regulation of apoptosis, thereby controlling the balance between cell
growth and cell death [90]. A more recent study has shown that the
anti-apoptotic BCL-2 homolog MCL1 acts as a stress sensor that coor-
dinately controls autophagy and apoptosis. The ﬁnal outcome is de-
termined by the interplay between BAX and Beclin 1 activation
downstream of MCL1 degradation. Consistent with the potential
role for TOR in modulating both autophagy and apoptosis, mTOR inhi-
bition following nutrient deprivation has been suggested to cause
MCL1 degradation [91]. Despite the well-established role of TOR in
positively and negatively regulating several anabolic and catabolic
processes respectively, further investigation is required for a better
understanding of the molecular mechanisms that underlie the action
of TOR as apoptosis inducer or effective inhibitor.
3.2. Beclin 1: at the crossroads between autophagy and apoptosis
Beclin 1, the mammalian ortholog of yeast Atg6, has a critical role
in autophagosome formation as a component of a multiprotein class
III phosphatidyl inositol-3 kinase (PI3K) complex, which also includes
VPS34 and VPS15, among others (Fig. 3; [92,93]). Beclin 1 is
expressed in many human and murine tissues. Similarly, bec-1, the
Caenorhabditis elegans ortholog of mammalian beclin 1, is expressed
in all tissues that are remodeled during dauer larval formation
(a stage of developmental arrest). bec-1 is essential during embryo-
genesis and is required for normal dauer development and adult
lifespan [94]. Moreover, loss of beclin 1 contributes to embryonic le-
thality in mice and to increased tumor incidence in beclin 1+/−
mice. These phenotypes are tightly associated with defects in autoph-
agy with no apparent defect in apoptotic cell death [95]. It is well-
documented that the crosstalk between autophagy and apoptosis is
mediated at least in part by the functional and structural interaction
between Beclin 1 and the anti-apoptotic proteins BCL-2 and BCL-XL
[96,97]. The Beclin 1/BCL-2 interaction appears to be evolutionarilyconserved. In C. elegans, BEC-1 forms two functionally distinct com-
plexes with the BCL-2 homolog CED-9 and with LET-512/VPS34.
BEC-1-depleted larvae lack the lipid product PtdIns 3-phosphate of
LET-512/VPS34 supporting the view that BEC-1 is required for the
function of LET-512/VPS34, which has essential roles in autophagy,
membrane trafﬁcking and endocytosis. Moreover, inactivation of
bec-1 triggers apoptosis as evidenced by the increased number of ap-
optotic cell corpses in somatic tissues and in the germline of animals
[97]. Together these ﬁndings suggest that BEC-1 acts as a crucial reg-
ulator of both autophagy and apoptosis. The structural basis of Beclin
1/BCL-2/BCL-XL interaction has recently been elucidated. Beclin 1
possesses a BCL-2 homology (BH) 3 region, which physically interacts
with BCL-2/BCL-XL proteins [98]. BH3 domains can bind to BH3 recep-
tors and inhibit the anti-apoptotic BCL-2 proteins, such as BCL-2 and
BCL-XL, or activate the pro-apoptotic BCL-2 family members, such as
BAX and BAK [99]. Interestingly, mutations in BH3 domain of Beclin
1 or the BH3 receptor domain of BCL-XL disrupt the physical interac-
tion between Beclin 1 and BCL-XL, thereby abolishing the BCL-XL-
mediated inhibition of autophagy. Notably, BCL-2 targeted speciﬁcally
to the ER and not to mitochondria can effectively inhibit starvation-
induced autophagy in yeast and mammalian cells and in the heart
muscle of transgenic mice co-expressing cardiac BCL-2 and the ﬂuo-
rescent autophagy marker GFP-LC3 [96]. It has been shown that
siRNA-mediated depletion or deletion of the BH3-only protein Bad re-
duces starvation-induced autophagy, whereas transfection-enforced
overexpression of BAD or addition of the pharmacological BH3-
mimetics is sufﬁcient to induce autophagy in human cells. Similarly,
EGL-1 deﬁciency, the sole BH3-only protein from C. elegans, compro-
mises starvation-induced autophagy, while gain-of-function muta-
tion of EGL-1 stimulates autophagy [98]. Together, these ﬁndings
indicate that BH3-only proteins or BH3 mimetics act not only as cell
death inducers, but also as autophagy regulators. Intriguingly, al-
though the binding of BCL-2 to Beclin 1 reduces the capacity of Beclin
1 to activate autophagy, and despite the fact that Beclin 1 contains a
BH3-only motif typical of pro-apoptotic proteins, Beclin 1 fails to
modulate the anti-apoptotic potential of BCL-2 and thus, to induce
apoptosis. The fact that binding of Beclin 1 to BCL-2 does not modify
apoptosis even in autophagy-deﬁcient Atg5−/−mouse embryonic ﬁ-
broblasts (MEF) argues against a protective role for Beclin 1-mediated
autophagy [100].
3.3. Caspases as modulators of autophagy
Recent ﬁndings provide new insights into the mechanisms under-
lying the molecular interplay between autophagy and apoptosis.
Withdrawal of the obligatory interleukin 3 (IL3) growth factor from
murine hematopoietic cell line induces autophagy as a pro-survival
mechanism followed by apoptotic cell death if deprivation is
sustained. Induction of apoptosis upon growth factor depletion is as-
sociated with caspase-mediated cleavage of Beclin 1 and PI3K. This
event impairs the autophagic function of Beclin 1. Furthermore, cleav-
age of Beclin 1 and PI3K occurs independently of the cell type and the
apoptotic trigger either intrinsic (through release of mitochondrial
pro death factors) or extrinsic (death receptor-dependent). Impor-
tantly, the C-terminal fragment of Beclin 1 generated by caspase-
mediated cleavage localizes to mitochondria and sensitizes cells to
apoptosis, probably through release of pro-apoptotic factors (Fig. 3)
[101]. The ﬁnding that the pro-apoptotic protein BAX reduces au-
tophagy by enhancing caspase-mediated cleavage of Beclin 1 at
D149 and the fact that non-caspase cleavable Beclin 1, as well as,
BCL-XL can rescue BAX-induced autophagy, indicates that apoptosis
can suppress autophagy [102]. Further supporting the link between
autophagy and apoptosis, accumulating evidence reveals that other
autophagy proteins are also substrates for caspase-induced apoptosis.
Caspase-3 cleaves human ATG4D, a cysteine protease that in turn
cleaves the C-terminus of newly synthesised ATG8 (called LC3 in
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naling. The extrinsic pathway is initiated by the ligation of death receptors with their cognate ligands, such as FASL, TRAIL or TNF. As a consequence, an adaptor molecule, FADD
(FAS-associated death domain protein), couples death receptors and subsequently activates caspase-8. Activated caspase-8 can directly cleave and activate caspase-7 and
caspase-3, thus promoting apoptosis. The intrinsic pathway is modulated by the activation of BH3-only proteins sensing different types of cell stress, such as DNA damage or ER
stress, and then activating BAX/BAK at mitochondrial outer membrane (MOM). MOM permeabilization (MOMP) leads to release of different apoptosis-mediating molecules,
such as cytochrome c, which activates caspase-9. In turn, caspase-9 cleaves and activates caspase-3 and caspase-7, thus triggering apoptotic cell death. Both pathways interface
at the point of caspase-3 activation. Autophagosome formation requires Beclin 1 acting as a component of a multiprotein (PI3K) complex together with VPS34 and VPS15,
among others. The crosstalk between autophagy and apoptosis is mediated at least in part by the functional and structural interaction between Beclin 1 and the anti-apoptotic pro-
teins BCL-2 and BCL-XL. Diverse apoptotic stimuli either intrinsic or extrinsic can lead to caspase-mediated cleavage of Beclin 1. As a consequence, Beclin 1 loses its ability to induce
autophagy. Instead, its C-terminal fragment translocates to mitochondria, thereby sensitizing cells to apoptosis. In contrast to Beclin 1 and ATG5, which lose their ability to induce
autophagy upon cleavage, caspase-cleaved ATG4D acquires enhanced autophagy activity. p53 has essential roles in both apoptosis and autophagy. At the transcriptional level, p53
upregulates BAX, PUMA and BID or reduces the expression of BCL-2, which antagonizes BAX. In addition to apoptosis, p53 can also induce autophagy through TOR inhibition and
also through transcriptional activation of DRAM. Intriguingly, cytoplasmic p53 inhibits autophagy indicating a complex relationship between p53 and autophagy/survival pathways.
DAPK, a calcium/calmodulin regulated Ser/Thr kinase, has also been linked to both apoptosis and autophagic cell death. Arrows indicate stimulatory inputs. Bars indicate inhibitory
interactions. For clarity, some of the signaling connections between autophagy and apoptosis are not shown. See text for details.
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and delipidation activities against the yeast Atg8 paralog GABARAP-L1
(γ-aminobutyric acid receptor-associated protein-like 1). Silencing
ATG4D expression suppresses autophagy and sensitizes cells to starva-
tion and staurosporine-induced cell death. This supports the hypothesis
that caspases stimulate ATG4D-mediated autophagy to promote the
survival of starved cells. Interestingly, overexpression of caspase-
cleaved ATG4D induces apoptosis in human cells that is preceded by
the rapid recruitment of ATG4D to mitochondria [103]. ATG5, which is
required for the formation of autophagosomes, also enhances suscepti-
bility to apoptotic stimuli upon cleavage by caspase. Truncated ATG5
translocates to mitochondria, where it modulates themitochondrial ap-
optotic pathway [104]. Noteworthy, caspase-mediated cleavage of ATG5
and Beclin 1 switches autophagy to apoptosis, while cleavage of ATG4D
results in a truncated product with increased autophagic activity
(Fig. 3). Together, these ﬁndings bear important implications for dis-
ease, in particular cancer pathogenesis and treatment.3.4. Anti-apoptotic FLIPs as anti-autophagic mediators
In support of the complex crosstalk between the autophagic and
apoptotic machinery, a recent study has revealed a novel function of
the anti-apoptotic protein FLIP (Flice inhibitory protein), as a negative
regulator of autophagy. The cellular and viral orthologs of the
FADD-like interleukin-1 beta-converting enzyme (FLICE)-like inhibi-
tor proteins (c-FLIP and v-FLIP, respectively) are known inhibitors
of apoptosis triggered by death receptors of the TNF/NGF (tumor ne-
crosis/nerve growth factor) family. Compelling evidence suggests
that FLIPs compete with LC3 for binding with ATG3, an E2-like en-
zyme, under normal conditions. As a consequence, FLIPs prevent the
ATG3-mediated elongation of autophagosomes, thereby decreasing
the levels of autophagy. However, under conditions of stress, FLIPs
allow ATG3–LC3 interaction, thus inducing autophagy. Collectively,
FLIPs act not only as anti-apoptotic factors but also as suppressors of
autophagy through their inhibitory interaction with ATG3[105].
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autophagy
DAPK is a calcium/calmodulin regulated Ser/Thr kinase that medi-
ates cell death induced by diverse death signals. DAPK acts as a tumor
suppressor, whose expression is lost in many tumor types, mainly
owing to DNA methylation (reviewed in ref. [106]). DAPK has been
linked to both apoptosis and autophagic cell death. DAPK becomes acti-
vated during ER stress, which in turn triggers amixed apoptotic and au-
tophagic cell death response. Moreover, DAPK knockout confers
protection against ER stress both in vitro in isolated ﬁbroblasts and in
vivo in a mouse kidney toxicity model. The ﬁnding that both apoptosis
and autophagy are attenuated in these experimental settings, supports
the view that DAPK integrates signals from apoptotic and autophagy
pathways to induce cell death during ER stress [107]. The role of DAPK
in the regulation of autophagy has been established in mammalian
cell culture [108] and in C. elegans, where downregulation of dapk-1,
the worm ortholog of DAPK, by mutation or RNAi knockdown reduces
starvation-induced autophagy in the pharyngeal muscles [109]. How-
ever, the mechanisms through which DAPK promotes autophagy are
not entirely clear. A recent study, which addresses this issue, has
identiﬁed Beclin 1 as a target of DAPK (Fig. 3). DAPK-mediated phos-
phorylation of Beclin 1 on Thr119 at the BH3 domain promotes the dis-
sociation of Beclin 1 from its inhibitor BCL-2-family members, thereby
activating Beclin 1 to induce autophagy [110].
3.6. The role of p53 in autophagy and apoptosis
As already mentioned earlier, p53 is activated by a broad range of
stressful conditions in the cell, such as DNA damage, hypoxia, or aber-
rant oncogene expression to promote cell-cycle checkpoints, DNA re-
pair, cellular senescence, and apoptosis [111]. The role of p53 as
regulator of apoptosis in both the extrinsic and the intrinsic pathways
has been extensively studied. p53 functions to integrate distress sig-
nals and induce apoptosis through either the transcriptional activa-
tion of the ‘multidomain’ BCL-2 family member BAX, the ‘BH3-only’
members PUMA and BID or the attenuation of BCL-2 expression,
which antagonizes BAX (Fig. 3). Notably, p53-induced apoptosis is
often context dependent. For example, Bax deﬁciency compromises
p53-mediated apoptosis in oncogenically transformed ﬁbroblasts,
but has no obvious effect on p53-mediated apoptosis in normal thy-
mocytes (reviewed in ref. [112]). In addition to controlling transcrip-
tion of proapoptotic members of the BCL-2 family, p53 can also
transactivate components of the core apoptotic machinery, such as
the gene encoding APAF1, which acts as a co-activator of caspase-9.
Moreover, p53 can transcriptionally regulate the expression of the ef-
fector caspase-6. Although p53 can also activate the transcription of
genes acting in the extrinsic apoptotic pathway, its action in apopto-
sis proceeds primarily through the intrinsic program. Surprisingly,
beyond its transactivation functions, p53 has transrepression abilities
as well, that may contribute to apoptosis [112]. While most studies
have focused on the apoptotic activity of p53, several recent reports
have highlighted the functional link between p53 and autophagy.
p53 can stimulate autophagy by inhibiting mTOR via activation of
the AMP kinase [113] or through the transactivation of DRAM
(damage-regulated autophagy modulator), a gene encoding a lyso-
somal protein that induces autophagy (Fig. 3). Induction of autophagy
by p53 via DRAM contributes to apoptotic cell death in response to
genotoxic stress. Therefore, DRAM appears to be a critical component
of the network that controls p53-mediated apoptosis and autophagy
[114]. Interestingly, emerging ﬁndings unravel additional activities
of p53 in the cytoplasm, where it triggers apoptosis and blocks
autophagy. Deletion, depletion or pharmacological inhibition of p53
induces autophagy in human, mouse and nematode cells. Enhanced
autophagy improves the survival of p53-deﬁcient cancer cells under
conditions of hypoxia and nutrient depletion, suggesting thatautophagy induced by p53 inhibition serves a cytoprotective function.
Notably, cytoplasmic, but not nuclear, p53 can repress the enhanced
autophagy of p53-deﬁcient cells, implying a complex role for p53 in
regulation of autophagy. Compelling evidence suggests that the
AMP kinase (AMPK) is activated, while the mammalian target of
rapamycin (mTOR) nutrient sensing kinase is inhibited in p53−/−
cells. Given the crucial role that AMPK and mTOR play in the regula-
tion of autophagy, it is possible that p53 inhibition controls autopha-
gy through the AMPK/mTOR-dependent pathway [115]. Overall,
these ﬁndings indicate that p53 modulates autophagy depending on
its subcellular localization [55]. Collectively, p53 links autophagy
and apoptosis in a complex, context-dependent manner, aiming to re-
store cellular and organismal homeostasis.
3.7. Mitoptosis
Mitoptosis is a mitochondrial suicide process, which occurs pri-
marily as a consequence of mitochondrial outer membrane perme-
abilization (MOMP) and subsequent potential loss. A recent study
has shown that after Bax/Bak-mediated MOMP, a mitochondrial
intermembrane space (IMS) protein, namely DDP/TIMM8a, is re-
leased into the cytoplasm where it binds to Drp1. This interaction ac-
tivates Drp1-mediated mitochondrial ﬁssion and subsequently
mitoptosis [116]. Mitochondrial dysfunction and the production of
ROS are major factors triggering mitoptosis. Interestingly, accumulat-
ing evidence suggests that programmed destruction of mitochondria
can lead to induction of autophagy. Indeed, recent studies have indi-
cated that elimination of malfunctioning mitochondria may occur ei-
ther through autophagosome formation via selective mitochondrial
autophagy (mitophagy) [117] or through the formation of mitoptotic
bodies, which are then released into the extracellular space via atyp-
ical exocytosis [118]. Lastly, it was reported that proteosomal inhibi-
tion by a prototypic proteasome inhibitor, MG132, in epithelial cancer
cells activates a BAX/BAK-independent mitoptosis [119]. However,
further characterization of the molecular mechanisms underlying
mitoptosis is needed to unravel its pathophysiological signiﬁcance.
4. Crosstalk between autophagy and necrosis
The interplay between autophagy and necrosis is rather complex.
These processes can be activated in parallel or sequentially, and have ei-
ther common or opposite objectives. The ability of autophagy to sup-
press various forms of necrotic cell death is considered to be one of
themost important pro-survival functions of autophagy that is achieved
either by blocking apoptosis or suppressing necrotic cell death.
4.1. Autophagy and necroptosis
Autophagy and necroptosis are intricately interlinked processes.
The molecular underpinnings of this relationship remain largely elu-
sive and somewhat controversial; autophagy has been shown to ei-
ther promote [120], suppress [121,122] or not link with necroptosis
[123].
Several studies converge to demonstrate that in response to TNFa,
antigen stimulation and starvation, autophagy is activated to block
necroptosis in several cell lines, such as L929 cells, lymphocytes and
cancer cells [121,122]. zVAD, a short peptide that acts as a general
caspase inhibitor preventing apoptosis, triggers necroptosis in re-
sponse to TNFa treatment [124]. The fact that zVAD can robustly in-
duce necroptosis and prevent autophagy through its inhibitory
effect on lysosomal cathepsins, underscores the pro-survival function
of autophagy against necroptosis. The pro-survival function of au-
tophagy in zVAD-induced necroptosis is also highlighted by the ob-
servation that inhibition of autophagy via the mTOR signaling
pathway enhances necroptosis, while starvation protects against
zVAD-induced necroptotic cell death [86,124–126].
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regulation of a number of processes including transcription, apoptosis,
stress resistance and ageing [127]. Accumulating evidence implicates
sirtuins both in autophagy and necroptosis. Indeed, Sirt1 forms a com-
plex with, and deacetylates several autophagy components, such as
ATG5, ATG7 and ATG8, to induce autophagy [128]. In addition, the
FOXO1 transcription factor has been shown to dissociate from SIRT2
in response to oxidative stress or starvation, in human cancer cells. In
turn, FOXO1 becomes acetylated and binds to ATG7, inducing autopha-
gy [129]. Recent ﬁndings indicate that SIRT2 is also involved in the reg-
ulation of necroptosis [130]. SIRT2 associates with RIP3 and mediates
RIP1 deacetylation in response to TNFα stimulation. As a consequence,
RIP1 and RIP3 directly interact and form complex II, triggering
necroptosis [130]. These early observations suggest a functional link be-
tween autophagy and necroptosis. However, much still remains to be
uncovered about the molecular mechanisms underlying the complex
interplay between these two processes.Oxidative stress4.2. Autophagy and PARP-mediated necrosis
As already mentioned earlier, PARP1 belongs to a family of nuclear
enzymes, modulating DNA repair, transcriptional regulation, chromatin
modiﬁcation and genomic stability through polyADP-ribosylation
[131,132]. PARP1 over-activation leads to ATP depletion, thereby induc-
ing necrotic cell death and preventing energy-dependent apoptosis
[7,28,133]. Interestingly, PARP1 activation interfaces with signaling
pathways known to promote autophagy. AMPK (AMP-activated kinase)
functions as a cellular energy biosensor, activated upon ATP depletion
[134]. AMPK promotes autophagy either through inhibition of the
mTOR signaling pathway (Fig. 3; [135,136]), or through activation of
theULK1 complex [137,138]. PARP1 activation in response toDNAdam-
age can lead sequentially to ATP depletion, AMPK activation, inhibition
of mTOR and autophagy induction [139–141]. DNA damage-induced
autophagy acts as a pro-survival mechanism to protect against necrotic
cell death resulting fromPARP1 activation. Together theseﬁndings indi-
cate that PAPR1 elicits opposing functions upon activation; induction of
necrosis due to ATP depletion and at the same time protection against
cell death through induction of autophagy. The ﬁnal life-or-death out-
come depends on the ﬁne balance between autophagy and necrosis.
In this setting, pro-survival induction of autophagy serves as the last re-
sort before cell death under extreme stress conditions. ER stress
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Fig. 4. The DAPK–PKD pathway coordinates the induction of apoptosis, necrotic cell
death and autophagy. Under harsh stimuli DAPK functions as a signal mediator that co-
ordinates the induction of apoptosis, necrosis and autophagy. DAPK becomes activated
under stress conditions such as oxidative and ER stress. In turn, DAPK activates PKD
through phosphorylation. PKD activation induces either caspase-independent cell
death or autophagy. PKD binds and directly phosphorylates VSP34. VSP34 is involved
in the formation of the autophagosomal membrane. DAPK also phosphorylates Beclin
1. Upon phosphorylation, Beclin 1 is released from inhibitory BCL-2 association and au-
tophagy commences.4.3. Autophagy and necrosis: the involvement of the DAPK–PKD pathway
PKD (Protein Kinase D1) is a serine/threonine kinase involved in
many cellular processes such as cell proliferation, cell motility and cell
death [142], and is activated upon oxidative stress [143,144]. Accumu-
lation of large amounts of ROS (reactive oxygen species) eventually
causes cellular damage and activates several cellular responses includ-
ing autophagy, apoptosis and necrosis. Stimulation of autophagy pro-
motes cell survival through elimination of damaged proteins and
organelles preserving cellular homeostasis [145,146]. Recent ﬁndings
reveal that PKD acts as a novel regulator of autophagy under oxidative
stress [147], whereby it phosphorylates VSP34 to promote auto-
phagosomal formation (Fig. 4). The DAPK (death-associated protein ki-
nase), which also responds to oxidative stress and is known to induce
autophagy through phosphorylation of Beclin1, releasing it from
BCL-XL (Fig. 3; [110]), activates PKD through phosphorylation [148]. In-
terestingly, PKD acts downstream of DAPK, with both of them required
to induce autophagy under oxidative stress [147]. Thus, DAPK coordi-
nates the induction of autophagy through two distinct mechanisms
under stress conditions: First, through phosphorylation of Beclin1 and
second, through phosphorylation of PKD, which in turn phosphorylates
VSP34 to activate autophagy (Fig. 4).5. Outlook
Recent ﬁndings have linked the three major routes to cell death, ap-
optosis, necrosis and autophagy in various ways, placing the ﬁeld on a
new and exciting base. With the development of ever better imaging
technologies and more speciﬁc pharmacological inhibitors, our under-
standing of cell death processes is set to expand. New sub-modes of cel-
lular demise are likely to appear as we are progressively more able to
characterize the death pathways in different cell types and upondiverse
death triggers. One such example is a recent study investigating the
death of mouse embryonic stem cells upon treatment with etoposide,
a topoisomerase-II DNA damaging agent. While cell death was both
caspase- and necroptosis-independent, it was partially dependent on
the activity of lysosomal proteases. A role for autophagy in the cell
death process was eliminated, suggesting that etoposide induces a
novel form of programmed cell death in this cellular context. Inhibition
of p53 either as a transcription factor by piﬁthrin α or in its mitochon-
drial role by piﬁthrin μ signiﬁcantly ameliorated cell death. Finally,
EndoG was identiﬁed as a novel protease participating in the DNA frag-
mentation observed in this process. The authors of the report coined the
term “charontosis” after Charon, the ferryman of the dead in Greekmy-
thology, to describe this distinct form of program cell death in mouse
embryonic stem cells [149].
The upcoming challenge will be to understand how these novel
emerging relationships are related to developmental processes and
pathological conditions, as opposed tomodels created in vitro. Although
someprogress towards this end has beenmade, especially in the ﬁeld of
immunology, there is a long way ahead and numerous diseases to in-
vestigate. The results of such efforts are eagerly anticipated as they are
likely to form the basis for novel and context-speciﬁc pharmacological
interventions.
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